4.6 Letter

Appearance of a BRAF Mutation Conferring Resistance to Crizotinib in Non-Small Cell Lung Cancer Harboring Oncogenic ROS1 Fusion

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 13, Issue 4, Pages E66-E69

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2017.11.125

Keywords

-

Funding

  1. Japan Agency for Medical Research and Development [17ck0106255h0001]
  2. National Cancer Center Research and Development Fund

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available